ungeremine has been researched along with arginyl-glycyl-aspartic acid in 2 studies
| Studies (ungeremine) | Trials (ungeremine) | Recent Studies (post-2010) (ungeremine) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
|---|---|---|---|---|---|
| 27 | 0 | 11 | 4,556 | 17 | 1,799 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Fu, Y; Gong, T; Song, X; Yang, L; Zhang, Z | 1 |
| Chen, T; Fu, Y; Gong, T; Zhang, Z; Zhao, T | 1 |
2 other study(ies) available for ungeremine and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Hormonal; Cell Proliferation; Central Nervous System Neoplasms; Drug Delivery Systems; Glioma; Indolizines; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Octreotide; Oligopeptides; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 2017 |
A comparison study between lycobetaine-loaded nanoemulsion and liposome using nRGD as therapeutic adjuvant for lung cancer therapy.
Topics: Adjuvants, Pharmaceutic; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Emulsions; Indolizines; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanostructures; Neoplasms, Experimental; Oligopeptides; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2018 |